Stock Events

Stock Events

Staar Surgical 

$23.47
53
-$0.11-0.45% Friday 20:00
+$0.00+0%Friday 20:04After hours

Statistics

Day High
23.53
Day Low
23.46
52W High
35.87
52W Low
15.59
Volume
54,663
Avg. Volume
-
Mkt Cap
1.18B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.6
-0.27
0.07
0.41
Expected EPS
0.047036
Actual EPS
N/A

Financials

-33.6%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
239.44MRevenue
-80.45MNet Income

Analyst Ratings

28.71Average Price Target
The highest estimate is 37.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
29%
Hold
57%
Sell
14%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow STAA. It's not an investment recommendation.
Microsoft
11
MSFT
NVIDIA
11
NVDA
Amazon
10
AMZN
Netflix
10
NFLX

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson's vision care division competes directly with Staar Surgical in the eye health market, particularly in products related to cataract and refractive surgery.
Alcon
ALC
Mkt Cap34.81B
Alcon specializes in eye care products, including surgical devices and equipment for cataract and refractive surgery, directly competing with Staar Surgical's product offerings.
Cooper Companies
COO
Mkt Cap13.88B
The Cooper Companies operate through CooperVision, which competes in the contact lens market, and CooperSurgical, which, while more focused on women's health, has overlaps in surgical products that can compete with Staar's offerings.
Bausch Health Companies
BHC
Mkt Cap2.36B
Bausch Health Companies, through its division Bausch + Lomb, competes in the eye health sector, offering products that range from contact lenses to surgical devices, overlapping with Staar Surgical's market.
Novartis
NVS
Mkt Cap292.35B
Novartis, through its Alcon eye care division before its spin-off, was a direct competitor, and continues to have interests in the healthcare sector that indirectly compete with Staar Surgical's eye surgery products.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie, after acquiring Allergan, competes in the eye care market, particularly with products for eye health and surgery, which can be seen as indirect competition to Staar Surgical's offerings.
Eco Science Solutions
ESSI
Mkt Cap26,479
EyeSys Technologies is a smaller player but competes in the corneal topography market, which is relevant for pre-surgical assessments in procedures that Staar Surgical's products are used for.

About

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
Show more...
CEO
Warren Foust
Employees
957
Country
United States
ISIN
US8523123052
WKN
000870353

Listings

STU
DE
SR3.STU
MU
DE
SR3.MU
F
DE
SR3.F
XNAS
US
STAA

0 Comments

Share your thoughts

FAQ

What is Staar Surgical stock price today?▼
The current price of STAA is $23.47 USD — it has decreased by -0.45% in the past 24 hours. Watch Staar Surgical stock price performance more closely on the chart.
What is Staar Surgical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Staar Surgical stocks are traded under the ticker STAA.
Is Staar Surgical stock price growing?▼
STAA stock has risen by +6.15% compared to the previous week, the month change is a +2.67% rise, over the last year Staar Surgical has showed a -16% decrease.
What is Staar Surgical market cap?▼
Today Staar Surgical has the market capitalization of 1.18B
When is the next Staar Surgical earnings date?▼
Staar Surgical is going to release the next earnings report on November 04, 2026.
What were Staar Surgical earnings last quarter?▼
STAA earnings for the last quarter are 0.16 USD per share, whereas the estimation was 0.22 USD resulting in a -27.72% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Staar Surgical revenue for the last year?▼
Staar Surgical revenue for the last year amounts to 239.44M USD.
What is Staar Surgical net income for the last year?▼
STAA net income for the last year is -80.45M USD.
How many employees does Staar Surgical have?▼
As of September 05, 2026, the company has 957 employees.
In which sector is Staar Surgical located?▼
Staar Surgical operates in the Health & Wellness sector.
When did Staar Surgical complete a stock split?▼
Staar Surgical has not had any recent stock splits.
Where is Staar Surgical headquartered?▼
Staar Surgical is headquartered in MONROVIA, United States.